New 52 Week Low Today

Bristol-Myers Squibb Co BMY:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 05/21/24 EDT

42.34

+0.07 (+0.17%)

Volume

1,457,294

42.27UNCH (UNCH)

Volume

16,088,518

52 week range

42.25 - 67.16

Open43.14
Day High43.43
Day Low42.25
Prev Close43.36
52 Week High67.16
52 Week High Date05/23/23
52 Week Low42.25
52 Week Low Date05/21/24

Key Stats

Market Cap85.686B
Shares Out2.03B
10 Day Average Volume12.57M
Dividend2.40
Dividend Yield5.68%
Beta0.44
YTD % Change-17.62

KEY STATS

Open43.14
Day High43.43
Day Low42.25
Prev Close43.36
52 Week High67.16
52 Week High Date05/23/23
52 Week Low42.25
52 Week Low Date05/21/24
Market Cap85.686B
Shares Out2.03B
10 Day Average Volume12.57M
Dividend2.40
Dividend Yield5.68%
Beta0.44
YTD % Change-17.62

RATIOS/PROFITABILITY

EPS (TTM)-3.10
P/E (TTM)-13.62
Fwd P/E (NTM)72.01
EBITDA (TTM)20.391B
ROE (TTM)-25.45%
Revenue (TTM)45.534B
Gross Margin (TTM)75.94%
Net Margin (TTM)-13.47%
Debt To Equity (MRQ)337.64%

EVENTS

Earnings Date07/26/2024(est)
Ex Div Date04/04/2024
Div Amount0.60
Split Date-
Split Factor-

Latest On Bristol-Myers Squibb Co

Trade Tracker: Goldman Sachs, Bristol Myers and TJXMay 17, 2024CNBC.com
J&J, Bristol Myers Squibb lose challenges to Medicare drug-price negotiationsApril 29, 2024CNBC.com
Cramer: 5 sectors of the market that are working and stocks that stand out in eachApril 28, 2024CNBC.com
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly lossApril 25, 2024CNBC.com
It’s the busiest week in earnings and these stocks could see a blow upApril 24, 2024CNBC.com

Content From Our Affiliates

Hold Rating on Bristol-Myers Squibb Amid Mounting Competition and Flat Growth ProjectionsMay 16, 2024TipRanks
Bristol Myers reports new four-year Sotyktu dataMay 16, 2024TipRanks
Bristol Myers’ Breyanzi CAR-T therapy approved by FDA in follicular lymphomaMay 15, 2024TipRanks
Wells Fargo Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)May 13, 2024TipRanks
Success Rate as High as 90% for AI-Discovered DrugsMay 10, 2024TipRanks

Profile

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric...

Christopher Boerner Ph.D.

Chairman of the Board, Chief Executive Officer, Chief Operating Officer

David Elkins

Executive Vice President, Chief Financial Officer, Member of the Leadership Team

Cari Gallman

Executive Vice President, Corporate Affairs, Member of the Leadership Team

Sandra Leung

Executive Vice President, General Counsel, Member of the Leadership Team

Adam Lenkowsky

Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team

Address

Route 206 And Province Line Road

Princeton, NJ

08543

United States

https://www.bms.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
GSK GSK plc	44.46	UNCH	UNCH
SNY Sanofi SA	48.95	UNCH	UNCH
GILD Gilead Sciences Inc	67.29	UNCH	UNCH
BAYRY Bayer AG	7.76	-0.11	-1.40%
PFE Pfizer Inc	28.56	UNCH	UNCH